Metastatic Liver Cancer: Clinical Trials

5 trials for Metastatic Liver Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 unknown. 5 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Recruiting 4, Unknown 1
Phase 13Recruiting 3

Follow Metastatic Liver Cancer: new trials by email Literature Review of Metastatic Liver Cancer trials Research Report on Metastatic Liver Cancer

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
Lu-PSMA-617 - Liver Cancer, Hepatocellular Carcinoma
Phase 2RecruitingMelissa Lumish102026-06-012026-05-08
Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC
EB-G3B7-NK dual-target CAR-NK cells, Fludarabine, Cyclophosphamide - Advanced Hepatocellular Carcinoma (HCC), Metastatic Liver Cancer
Phase 1 / Phase 2RecruitingBeijing Biotech302026-03-022026-03-30
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
ET140203 T Cells - Hepatoblastoma, Hepatocellular Carcinoma (HCC)
Phase 1 / Phase 2RecruitingEureka Therapeutics Inc.122022-07-192026-07-06
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
ECT204 T cells - Hepatocellular Carcinoma, Liver Cancer, Adult
Phase 1 / Phase 2RecruitingEureka Therapeutics Inc.602022-03-112026-09-10
Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE
acupoint electric stimulation, tropisetron - Nausea, Vomiting
Phase 2UnknownFudan University742013-06-012013-07-10

Narrower conditions

Liver Neoplasms (5)  ·  Carcinoma, Hepatocellular (3)  ·  Hepatoblastoma (1)  ·  Nausea (1)  ·  Simpson-Golabi-Behmel syndrome (1)  ·  Vomiting (1)

Broader conditions

Digestive System Diseases (5)  ·  Digestive System Neoplasms (5)  ·  Liver Diseases (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Adenocarcinoma (3)  ·  Carcinoma (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Complex and Mixed (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

Cyclophosphamide (1)  ·  Pluvicto (1)  ·  Tropisetron (1)  ·  fludarabine (1)

Sponsors

Eureka Therapeutics Inc. (2)  ·  Beijing Biotech (1)  ·  Fudan University (1)  ·  Melissa Lumish (1)

Countries

United States (3)  ·  China (2)  ·  Taiwan (1)

Top investigators

Pei Wang, PhD (2)  ·  Melissa Lumish, MD (1)  ·  Xiaoyan Zhu, Doc (1)

Results publications

PMID 28069044